Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The stress-induced kinase, c-Jun-N-terminal kinase 1 (JNK1) has previously been implicated in the pathogenesis of lung fibrosis. However, the exact cell type(s) wherein JNK1 exerts its pro-fibrotic role(s) remained enigmatic. Herein we demonstrate prominent activation of JNK in bronchial epithelia using the mouse models of bleomycin- or AdTGFβ1-induced fibrosis. Furthermore, in lung tissues of patients with idiopathic pulmonary fibrosis (IPF), active JNK was observed in various regions including type I and type II pneumocytes and fibroblasts. No JNK activity was observed in adjacent normal tissue or in normal control tissue. To address the role of epithelial JNK1, we ablated Jnk1 form bronchiolar and alveolar type II epithelial cells using CCSP-directed Cre recombinase-mediated ablation of LoxP-flanked Jnk1 alleles. Our results demonstrate that ablation of Jnk1 from airway epithelia resulted in a strong protection from bleomycin- or adenovirus expressing active transforming growth factor beta-1 (AdTGFβ1)-induced fibrosis. Ablation of the Jnk1 allele at a time when collagen increases were already present showed a reversal of existing increases in collagen content. Epithelial Jnk1 ablation resulted in attenuation of mesenchymal genes and proteins in lung tissue and preserved expression of epithelial genes. Collectively, these data suggest that epithelial JNK1 contributes to the pathogenesis of pulmonary fibrosis. Given the presence of active JNK in lungs from patients with IPF, targeting JNK1 in airway epithelia may represent a potential treatment strategy to combat this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Belumosudil, or KD025 is a ρ-associated coiled-coil kinase isoform 2 (ROCK2) inhibitor with several pathways of fibrotic modulation: increases pulmonary microvascular endothelial cell necrosis in hypoxia, strengthens the integrity of the pulmonary endothelial barrier, and increases oxidative phosphorylation and inhibits glycolysis in pulmonary microvascular endothelial cells [146–148].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [147]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840 · cited 1×
“As an independent measure of fibrosis, we also measured hydroxyproline content in the right superior lung lobe [24].”
MethodCommon and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456 · cited 1×
“Organ fibrosis has been estimated to contribute to 45% of all causes of mortality [1] and contributes to kidney, liver, and heart failure.”
BackgroundKim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257 · cited 2×
“Furthermore, activation of a partial epithelial to mesenchymal transition (EMT) phenotype in epithelial cells and resultant production of collagen [2] may also constitute a source of ECM in pulmonary fibrosis.”
BackgroundGenome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219 · cited 1×
“JNK effector activator protein (AP)-1 activity is reportedly increased by YAP/TAZ through JNK–YAP interaction [37] and YAP/TAZ activation promotes inflammation and atherogenesis by enhancing JNK [38].”
BackgroundLineage-negative progenitors mobilize to regenerate lung epithelium after major injury
Vaughan, A. E., Brumwell, A. N., Xi, Y., Gotts, J. E., Brownfield, D. G., Treutlein, B., Tan, K., Tan, V., Liu, F. C., Looney, M. R., et al. (2015) · Nature · doi:10.1038/nature14112 · Cited by 677 · cited 1×
“Lineage negative epithelial cells (LNEP) expressing keratin-5 and p63 [13, 14] also contribute to enhanced populations of epithelial cells in bleomycin-injured lungs, suggesting that airway epithelial cells contribute to alveolar remodeling and/or repair.”
BackgroundIntegrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
Wang, L., Luo, J.-Y., Li, B., Tian, X. Y., Chen, L.-J., Huang, Y., Liu, J., Deng, D., Lau, C. W., Wan, S., et al. (2016) · Nature · doi:10.1038/nature20602 · Cited by 668 · cited 1×
“JNK effector activator protein (AP)-1 activity is reportedly increased by YAP/TAZ through JNK–YAP interaction [37] and YAP/TAZ activation promotes inflammation and atherogenesis by enhancing JNK [38].”
BackgroundA Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604 · cited 1×
“Animals Mice with a germ-line mutation in the Jnk1 gene with LoxP elements inserted into two different introns (Jnk1) [20] were crossed with CCSP-rtTA and TetO-Cre bi-transgenic mice, in order to create CCSP-rtTA/tetO-Cre/ Jnk1 genotype.”
MethodSelf-citationXu, Y., Mizuno, T., Sridharan, A., Du, Y., Guo, M., Tang, J., Wikenheiser-Brokamp, K. A., Perl, A.-K. T., Funari, V. A., Gokey, J. J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90558 · Cited by 580 · cited 1×
“RNA profiling in individual epithelial cells from patients with IPF identified multiple distinct epithelial gene signatures, with features of mixed basal and alveolar characteristics, indicative of altered plasticity, and inadequate alveolar repair [30].”
BackgroundKönigshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O. V., Jahn, A., Rose, F., Fink, L., Seeger, W., Schaefer, L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33950 · Cited by 558 · cited 1×
“JNK1 can regulate both Smad and Wnt-signaling pathways, which has been implicated in epithelial cell fate, and epithelial plasticity [16, 17, 31].”
BackgroundFibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548 · cited 1×
“Notably, a fibrotic ECM scaffold was shown to lead to activation of control fibroblasts, while conversely, plating of activated myofibroblasts derived from IPF patients onto an ECM scaffold from control lungs resulted into a quiescent phenotype similar to control fibroblasts, suggesting that ECM is a prominent determi…”
Result
Cited by
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A., Liu, Y., & Zhang, J. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 284
Zhu, W. T., Li, Y., Zhao, J., Wang, Y., Li, Y., & Wang, Y. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2034931 · Cited by 90
Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis
Ptasinski, V., Stegmayr, J., Belvisi, M. G., Wagner, D. E., & Murray, L. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0476tr · Cited by 65
“, JNK) have been shown to be capable of regulating epithelial-cell behavior (126, 138, 160).”
BackgroundDiscovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001
Nagy, M. A., Hilgraf, R., Mortensen, D. S., Elsner, J., Norris, S., Tikhe, J. G., Yoon, W. H., Paisner, D., Delgado, M., Erdman, P. E., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01716 · Cited by 44
Popmihajlov, Z., Sutherland, D., Horan, G. S. B., Ghosh, A., Lynch, D. A., Noble, P. W., Richeldi, L., Reiss, T. F., & Greenberg, S. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001060 · Cited by 47
Metadata
- Authors
- van der Velden, J. L., Alcorn, J. F., Chapman, D. G., Lundblad, L. K. A., Irvin, C. G., Davis, R. J., Butnor, K., & Janssen-Heininger, Y. M. W.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- University of Vermont (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Janssen-Heininger, Yvonne M. W.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-01-14
- Volume
- 15
- Issue
- 1
- Pages
- e0226904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6959564
- OpenAlex
- W2999624847
- Cited by
- 32
- References
- 42
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 4
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL079331, HL060014, HL135828, HL095404)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- JNK1, pulmonary fibrosis, idiopathic pulmonary fibrosis, airway epithelium, bronchial epithelium, alveolar type II cells, bleomycin-induced fibrosis, conditional knockout, collagen deposition, mesenchymal gene expression, epithelial-mesenchymal transition, therapeutic target
- MeSH terms
- Dependovirus, Animals, Bleomycin, Disease Models, Animal, Epithelial Cells, Female, Humans, Lung, Male, Phosphorylation, Gene Deletion, Mitogen-Activated Protein Kinase 8, Mice, Transforming Growth Factor beta1, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models. https://app.cochat.ai/papers/10.1371/journal.pone.0226904
- The paper
- van der Velden, J. L., Alcorn, J. F., Chapman, D. G., Lundblad, L. K. A., Irvin, C. G., Davis, R. J., Butnor, K., & Janssen-Heininger, Y. M. W. (2020). Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models. PLOS ONE. https://doi.org/10.1371/journal.pone.0226904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.